Rapport Therapeutics Inc
RAPP14.050USD
-0.100-0.71%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
512.79MMarket Cap
LossP/E TTM
Rapport Therapeutics Inc
14.050
-0.100-0.71%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Total equity
Cash, cash equivalents and short-term investments
47.68%285.38M
--305.28M
--320.66M
--336.14M
--193.24M
- Cash and cash equivalents
-22.44%57.60M
--56.80M
--39.31M
--110.16M
--74.27M
-Short-term investments
91.45%227.78M
--248.47M
--281.35M
--225.97M
--118.98M
Prepaid expenses
1.90%5.48M
--4.42M
--5.17M
--4.42M
--5.38M
Other current assets
0.00%105.00K
--105.00K
--105.00K
--105.00K
--105.00K
Total current assets
46.42%290.97M
--309.80M
--325.94M
--340.67M
--198.73M
Non-current assets
Net Fixed Assets
98.14%10.87M
--4.97M
--5.02M
--5.24M
--5.49M
-Fixed Assets
109.54%12.08M
--5.94M
--5.72M
--5.73M
--5.77M
-Accumulated depreciation
333.69%1.21M
--965.00K
--705.00K
--485.00K
--279.00K
Other non-current assets
-89.82%211.00K
--160.00K
--189.00K
--189.00K
--2.07M
Total non-current assets
46.61%11.09M
--5.13M
--5.21M
--5.43M
--7.56M
Total assets
46.42%302.05M
--314.93M
--331.14M
--346.10M
--206.29M
Liabilities
Current liabilities
-Other payables
-41.68%3.81M
--1.90M
--1.55M
--3.44M
--6.54M
Accrued expenses
100.00%2.42M
--4.18M
--3.51M
--2.08M
--1.21M
Other current liabilities
-41.68%3.81M
--1.90M
--1.55M
--3.44M
--6.54M
Total current liabilities
-5.08%9.38M
--8.77M
--7.10M
--8.10M
--9.88M
Non-current liabilities
Long-term debt and lease liabilities
426.50%6.83M
--739.00K
--931.00K
--1.12M
--1.30M
-Long-term lease liabilities
426.50%6.83M
--739.00K
--931.00K
--1.12M
--1.30M
Other non-current liabilities
--0.00
----
----
----
----
Total non-current liabilities
426.50%6.83M
--739.00K
--931.00K
--1.12M
--1.30M
Total liabilities
45.01%16.22M
--9.51M
--8.03M
--9.21M
--11.18M
Shareholders' equity
Common equity
1414.77%433.74M
--429.69M
--426.48M
--423.30M
--28.63M
Retained earnings
-117.02%-147.81M
---123.75M
---103.77M
---86.23M
---68.11M
Capital reserves
1414.85%433.70M
--429.66M
--426.44M
--423.26M
--28.63M
Gains losses not affecting retained earnings
40.63%-95.00K
---522.00K
--400.00K
---183.00K
---160.00K
Total equity
46.50%285.84M
--305.43M
--323.11M
--336.89M
--195.11M
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
